TarlatamabTalquetamabDLL3 TCEtumor treatment
…the experimental window following engraftment with human PBMCs. Tarlatamab (DLL3 TCE) and Talquetamab (GPRC5D TCE) were evaluated in NCG-M…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: DLL3 TCE ×
DLL3 TCE
This drug is selected. Its supporting articles are shown below.